As of 2026-01-05, the Relative Valuation of Bolt Biotherapeutics Inc (BOLT) is (213.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.79 USD, the upside of Bolt Biotherapeutics Inc based on Relative Valuation is -3785.8%.
The range of the Relative Valuation is (129.82) - (286.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.8x - 12.9x | 9.6x |
| Forward P/E multiples | 5.8x - 13.0x | 9.6x |
| Fair Price | (129.82) - (286.32) | (213.41) |
| Upside | -2342.2% - -5045.0% | -3785.8% |
| Date | P/E |
| 2026-01-02 | -0.26 |
| 2025-12-31 | -0.25 |
| 2025-12-30 | -0.24 |
| 2025-12-29 | -0.24 |
| 2025-12-26 | -0.24 |
| 2025-12-24 | -0.23 |
| 2025-12-23 | -0.24 |
| 2025-12-22 | -0.25 |
| 2025-12-19 | -0.23 |
| 2025-12-18 | -0.23 |
| 2025-12-17 | -0.25 |
| 2025-12-16 | -0.25 |
| 2025-12-15 | -0.24 |
| 2025-12-12 | -0.24 |
| 2025-12-11 | -0.26 |
| 2025-12-10 | -0.26 |
| 2025-12-09 | -0.26 |
| 2025-12-08 | -0.24 |
| 2025-12-05 | -0.24 |
| 2025-12-04 | -0.24 |
| 2025-12-03 | -0.24 |
| 2025-12-02 | -0.22 |
| 2025-12-01 | -0.22 |
| 2025-11-28 | -0.23 |
| 2025-11-26 | -0.22 |
| 2025-11-25 | -0.23 |
| 2025-11-24 | -0.22 |
| 2025-11-21 | -0.21 |
| 2025-11-20 | -0.22 |
| 2025-11-19 | -0.21 |
| 2025-11-18 | -0.21 |
| 2025-11-17 | -0.20 |
| 2025-11-14 | -0.21 |
| 2025-11-13 | -0.21 |
| 2025-11-12 | -0.21 |
| 2025-11-11 | -0.22 |
| 2025-11-10 | -0.22 |
| 2025-11-07 | -0.20 |
| 2025-11-06 | -0.22 |
| 2025-11-05 | -0.22 |
| 2025-11-04 | -0.23 |
| 2025-11-03 | -0.25 |
| 2025-10-31 | -0.26 |
| 2025-10-30 | -0.26 |
| 2025-10-29 | -0.26 |
| 2025-10-28 | -0.26 |
| 2025-10-27 | -0.28 |
| 2025-10-24 | -0.27 |
| 2025-10-23 | -0.26 |
| 2025-10-22 | -0.25 |